Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedOct 27, 2023
DataAggregated Company Financials
Companies5
  • 7D1.5%
  • 3M-20.3%
  • 1Y-25.5%
  • YTD-28.9%

Over the last 7 days, the Biotech industry has risen 1.5%, driven by gains from Genmab of 2.1%. In contrast, the industry has lost 25% in the last 12 months. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 27 Oct 2023kr.160.8bkr.22.0bkr.4.7b18.6x34x7.3x
Sun, 24 Sep 2023kr.196.1bkr.22.0bkr.4.7b23x41.4x8.9x
Tue, 22 Aug 2023kr.187.2bkr.20.6bkr.3.9b35.3x47.4x9.1x
Thu, 20 Jul 2023kr.206.5bkr.19.5bkr.4.4b41.3x46.9x10.6x
Sat, 17 Jun 2023kr.208.1bkr.19.5bkr.4.4b44x47.2x10.6x
Mon, 15 May 2023kr.218.9bkr.17.9bkr.4.0b33.9x54.8x12.2x
Wed, 12 Apr 2023kr.201.8bkr.17.9bkr.3.5b31.4x57x11.3x
Fri, 10 Mar 2023kr.192.7bkr.17.9bkr.3.5b29.7x54.3x10.8x
Sun, 05 Feb 2023kr.201.8bkr.14.7bkr.3.3b30.8x61.7x13.7x
Tue, 03 Jan 2023kr.223.2bkr.14.7bkr.3.3b34.7x68.2x15.1x
Thu, 01 Dec 2022kr.241.4bkr.14.7bkr.3.3b37.7x73.8x16.4x
Sat, 29 Oct 2022kr.216.8bkr.12.4bkr.1.5b47.8x142.7x17.5x
Mon, 26 Sep 2022kr.181.0bkr.12.4bkr.1.5b40.2x121.6x14.6x
Wed, 24 Aug 2022kr.201.2bkr.12.2bkr.1.6b42.8x127.7x16.4x
Fri, 22 Jul 2022kr.198.9bkr.11.1bkr.130.5m71.6x1524.2x18x
Sun, 19 Jun 2022kr.149.8bkr.11.1bkr.130.5m54.8x1148x13.5x
Tue, 17 May 2022kr.150.9bkr.11.3bkr.52.5m58.1x2873.2x13.4x
Thu, 14 Apr 2022kr.182.6bkr.10.7bkr.622.4m55.6x293.5x17.1x
Sat, 12 Mar 2022kr.157.9bkr.10.7bkr.525.4m47.6x300.6x14.7x
Mon, 07 Feb 2022kr.165.7bkr.9.8bkr.117.9m51.3x1404.9x16.9x
Wed, 05 Jan 2022kr.192.6bkr.9.8bkr.117.9m58.1x1633.4x19.6x
Fri, 03 Dec 2021kr.188.6bkr.9.8bkr.117.9m56.1x1599x19.2x
Sun, 31 Oct 2021kr.219.1bkr.9.3b-kr.169,922,000.0075x-1289.1x23.5x
Tue, 28 Sep 2021kr.210.5bkr.9.3b-kr.169,922,000.0071.1x-1238.6x22.6x
Thu, 26 Aug 2021kr.225.6bkr.9.3b-kr.169,922,000.0078x-1327.9x24.3x
Fri, 02 Jul 2021kr.194.6bkr.9.3b-kr.169,922,000.0066.7x-1145.5x20.9x
Mon, 05 Apr 2021kr.166.9bkr.13.2bkr.3.5b24.4x47.6x12.6x
Thu, 07 Jan 2021kr.184.2bkr.12.3bkr.3.5b36.6x52.7x14.9x
Price to Earnings Ratio

32.1x


Total Market Cap: kr.160.5bTotal Earnings: kr.5.0bTotal Revenue: kr.13.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 79.4x202120222023
Current Industry PE
  • Investors are pessimistic on the Danish Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 34.0x which is lower than its 3-year average PE of 79.4x.
  • The 3-year average PS ratio of 15.2x is higher than the industry's current PS ratio of 7.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 18% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Danish Biotech compare with similar industries?

DK Market-1.14%
Healthcare-0.89%
Biotech1.46%
Biotech1.46%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB Genmabkr.2.03k2.1%
+kr.2.7b		-28.9%PE27.9x
BAVA Bavarian Nordickr.129.801.4%
+kr.136.1m		-43.9%PE9.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAVA

kr.129.80

Bavarian Nordic

7D

1.4%

1Y

-43.9%

GMAB

kr.2,028.00

Genmab

7D

2.1%

1Y

-28.9%

ZEAL

kr.302.80

Zealand Pharma

7D

-3.0%

1Y

63.1%

BIOPOR

kr.1.48

BioPorto

7D

-2.5%

1Y

-18.8%

ORPHA

kr.0.88

Orphazyme

7D

-4.3%

1Y

-21.4%